Cancer cells upregulate glucose transporters (GLUT1/3) and glycolytic enzymes (e.g., HK2, LDHA) to fuel rapid proliferation, outcompeting immune cells for glucose in the nutrient-scarce TME [9]. Here, SLC2A1 is linked to cancer.